Impact of single‐nucleotide polymorphisms in DNA repair pathway genes on response to chemoradiotherapy in rectal cancer patients: Results from ACCORD‐12/PRODIGE‐2 phase III trialValérie Boige, Pierre Laurent‐Puig, Isabelle Miran et al.|International Journal of Cancer|2019Cited by 11
Association of polymorphisms with tumor response in rectal cancer patients treated with capecitabine +/- oxaliplatine and radiation: Pharmacogenetic analysis of ACCORD-12/PRODIGE-2 trial.Valérie Boige, Pierre Laurent‐Puig, Caroline Mollévi et al.|Journal of Clinical Oncology|2016Cited by 0
Impact of Immune response-associated gene polymorphisms on tumor response in rectal cancer patients treated with capecitabine +/- oxaliplatine and radiation in the ACCORD-12/PRODIGE-2 phase III trialB. Valerie, Pierre Laurent‐Puig, Caroline Mollévi et al.|Annals of Oncology|2017Cited by 0
Impact of Immune response-associated gene polymorphisms on tumor response in rectal cancer patients treated with capecitabine +/- oxaliplatine and radiation in the ACCORD-12/PRODIGE-2 phase III trial.Valérie Boige, Pierre Laurent‐Puig, Isabelle Miran et al.|Journal of Clinical Oncology|2017Cited by 0